Raymond James Financial Services Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,727
| Closed | -$200K | – | 3272 |
|
|
2022
Q3 | $200K | Buy |
+3,727
| New | +$200K | ﹤0.01% | 2847 |
|
|
2019
Q3 | – | Sell |
-4,171
| Closed | -$297K | – | 2833 |
|
|
2019
Q2 | $297K | Buy |
4,171
+819
| +24% | +$58.3K | ﹤0.01% | 2281 |
|
|
2019
Q1 | $263K | Buy |
+3,352
| New | +$263K | ﹤0.01% | 2338 |
|
|
2018
Q4 | – | Sell |
-2,074
| Closed | -$355K | – | 2670 |
|
|
2018
Q3 | $355K | Sell |
2,074
-718
| -26% | -$123K | ﹤0.01% | 2162 |
|
|
2018
Q2 | $361K | Buy |
2,792
+573
| +26% | +$74.1K | ﹤0.01% | 2111 |
|
|
2018
Q1 | $229K | Buy |
+2,219
| New | +$229K | ﹤0.01% | 2176 |
|
|
2016
Q3 | – | Sell |
-2,764
| Closed | -$206K | – | 2308 |
|
|
2016
Q2 | $206K | Buy |
+2,764
| New | +$206K | ﹤0.01% | 1958 |
|
|
2015
Q4 | – | Sell |
-17,766
| Closed | -$949K | – | 1609 |
|
|
2015
Q3 | $949K | Buy |
+17,766
| New | +$949K | 0.02% | 790 |
|